drugset / Trial / NCT07489131
Clinical Study to Compare Efficacy and Safety of AVT29 and Eylea HD in Participants With Diabetic Macular Edema
RandomizedParallel-groupTriple-blindTreatment
Summary
This is a Randomized, Double-masked, Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea HD in Participants with Diabetic Macular Edema.
Timeline
- Start
- 2026-04-22
- Primary completion
- 2027-07
- Completion
- 2028-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AVT29 | Unknown | — | Intravitreal |
| Comparator | Aflibercept | Protein / enzyme biologic | — | Intravitreal |